Metformin rescues PGC-1α expression in presence of inhibitor. حسب Joel R. Frandsen (20685133)

الموضوعات:

Metformin increases PGC-1α and TFAM expression. حسب Joel R. Frandsen (20685133)

الموضوعات:

Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. حسب Joel R. Frandsen (20685133)

الموضوعات:

Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. حسب Joel R. Frandsen (20685133)

الموضوعات:

Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. حسب Joel R. Frandsen (20685133)

الموضوعات:

NTM infection induces mitochondrial damage and reduces mitochondria number. حسب Joel R. Frandsen (20685133)

الموضوعات:

The results of curve fitting analysis. حسب Hai-bo Ai (20790405)

Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. حسب Haipeng Luo (5322419)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Average proportion of first choice female applicants stratified by specialty category. حسب Lucy Hui (17538542)

الموضوعات:

Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease. حسب Haipeng Luo (5322419)

الموضوعات:

Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. حسب Haipeng Luo (5322419)

الموضوعات:

Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023. حسب Haipeng Luo (5322419)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023. حسب Haipeng Luo (5322419)

الموضوعات:

Gender differences in first choice match outcomes. حسب Lucy Hui (17538542)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات: